SNCA and Parkinson disease: Parkinson’s disease (PD) is an age-related neurodegenerative disease that is characterized by relatively selective nigrostriatal dopamine (DA) neurodegeneration and the presence of intraneuronal cytoplasmic inclusions called Lewy bodies, which are consistently immunostained with antibodies to α-synuclein (α-Syn).